XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
6 Months Ended
Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The compensation cost recognized in the condensed consolidated statements of income for our stock compensation arrangements was as follows:
 Three Months Ended 
 April 30,
Six Months Ended 
 April 30,
 2023202220232022
 (in thousands)
Cost of products$16,895 $13,078 $32,924 $24,285 
Cost of maintenance and service7,531 5,893 14,686 10,476 
Research and development expense75,355 58,109 144,586 107,649 
Sales and marketing expense26,937 19,291 51,844 37,092 
General and administrative expense16,540 13,690 33,445 26,330 
Stock-based compensation expense before taxes143,258 110,061 277,485 205,832 
Income tax benefit(23,193)(17,852)(44,925)(33,386)
Stock-based compensation expense after taxes$120,065 $92,209 $232,560 $172,446 
During the three and six months ended April 30, 2023, we recognized stock-based compensation expense relating to restricted stock units (RSUs), granted to senior executives with certain market, performance and service conditions (market-based RSUs). The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods were as follows:
 Three Months Ended 
 April 30,
Six Months Ended 
 April 30,
 2023202220232022
Expected life (in years)2.70 years1.69 years
 0.90 years - 2.70 years
1.69 years
Risk-free interest rate4.36 %1.33 %
4.36% - 4.63%
1.33 %
Volatility35.84 %33.01 %
35.84% - 42.86%
33.01 %
Grant date fair value$357.29 $280.82 
$357.29 - $408.55
$280.82 
As of April 30, 2023, we had $1.2 billion of total unrecognized stock-based compensation expense relating to options, RSUs and restricted stock awards, which is expected to be recognized over a weighted-average period of 2.5 years. As of April 30, 2023, we had $66.5 million of unrecognized stock-based compensation expense relating to our Employee Stock Purchase Plan, which is expected to be recognized over a period of approximately 2.0 years.
The intrinsic values of equity awards exercised during the periods were as follows:
 Three Months Ended 
 April 30,
Six Months Ended 
 April 30,
 2023202220232022
 (in thousands)
Intrinsic value of awards exercised$63,447 $46,464 $118,223 $159,389